Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pleuropulmonary Blastoma: later-stage trial registry
3 of 4 indexed Pleuropulmonary Blastoma trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Pleuropulmonary Blastoma: 4 US clinical trials tracked, 3 recruiting.
Pleuropulmonary Blastoma is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospitals and Clinics of Minnesota, running 2 of these trials.
Enrollment posture brief
Registry condition pleuropulmonary-blastoma
OPEN 3 | RECR 75% | LATE 1 | EARLY 0 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Pleuropulmonary Blastoma lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pleuropulmonary Blastoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pleuropulmonary Blastoma is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
International PPB/DICER1 Registry
Children's Hospitals and Clinics of Minnesota
NCT03382158
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
National Cancer Institute (NCI)
NCT01247597
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Children's Oncology Group
NCT06647953
International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
Children's Hospitals and Clinics of Minnesota
NCT01464606
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pleuropulmonary Blastoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pleuropulmonary Blastoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pleuropulmonary Blastoma page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Pleuropulmonary Blastoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospitals and Clinics of Minnesota sponsors the most Pleuropulmonary Blastoma trials on record, review their full trial history before evaluating a specific study. See Children's Hospitals and Clinics of Minnesota's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pleuropulmonary Blastoma condition card totals 4 registered trials; most-linked intervention Cyclophosphamide; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.